BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/19/2026 7:28:08 AM | Browse: 0 | Download: 0
Publication Name World Journal of Gastrointestinal Surgery
Manuscript ID 124385
Country China
Received
2026-06-23 10:12
Peer-Review Started
2026-06-23 10:12
First Decision by Editorial Office Director
Return for Revision
2026-07-15 07:41
Revised
2026-09-01 07:28
Publication Fee Transferred
2026-09-16 09:22
Second Decision by Editor
2026-10-10 03:25
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-10-10 09:08
Articles in Press
2026-10-10 09:08
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-10-14 01:50
Publish the Manuscript Online
2026-10-19 07:28
ISSN 1948-9366 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Meta-Analysis
Article Title Adjuvant chemoradiotherapy vs chemotherapy after R0 D2 gastrectomy for gastric cancer: Meta-analysis of randomized trials
Manuscript Source Unsolicited Manuscript
All Author List Han-Hao Lu, Jian-Hua Xie and Xiao-Rong Li
ORCID
Author(s) ORCID Number
Han-Hao Lu http://orcid.org/0009-0005-1448-1268
Funding Agency and Grant Number
Corresponding Author Han-Hao Lu, Department of Medical Oncology, Fujian Medical University, No. 134, Dongjie Street, Gulou District, Fuzhou 350000, Fujian Province, China. 18259385886@163.com
Key Words Gastric cancer; D2 lymphadenectomy; Adjuvant chemoradiotherapy; Chemotherapy; Randomized controlled trial; Meta-analysis
Core Tip This synthesis links eight randomized trials after R0 D2 gastrectomy. The all-era disease-free survival estimate favored chemoradiotherapy, but treatment-backbone and provenance analyses remained imprecise. These findings do not establish equivalence or exclude meaningful benefit. The published Adjuvant Chemoradiotherapy in Stomach Tumors 2 CI is used, and source-tagged numerical inputs and reproducible sensitivity calculations are supplied.
Publish Date 2026-10-19 07:28
Citation

Lu HH, Xie JH, Li XR. Adjuvant chemoradiotherapy vs chemotherapy after R0 D2 gastrectomy for gastric cancer: Meta-analysis of randomized trials. World J Gastrointest Surg 2026; 18(10): 124385

URL https://www.wjgnet.com/1948-9366/full/v18/i10/124385.htm
DOI https://doi.org/10.4240/wjgs.124385
Full Article (PDF) WJGS-18-124385-with-cover.pdf
PRISMA 2009 Checklist 124385-PRISMA-2009-Checklist.pdf
Manuscript File 124385_Auto_Edited_082526.docx
Answering Reviewers 124385-answering-reviewers.pdf
Audio Core Tip 124385-audio.mp3
Biostatistics Review Certificate 124385-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form 124385-conflict-of-interest-statement.pdf
Copyright License Agreement 124385-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate 124385-non-native-speakers.pdf
Supplementary Material 124385-supplementary-material.pdf
Peer-review Report 124385-peer-reviews.pdf
Scientific Misconduct Check 124385-scientific-misconduct-check.png
CrossCheck Report 124385-crosscheck-report.pdf